What Researchers Did
Researchers conducted a quasi-experimental study with 20 patients suffering from acute carbon monoxide poisoning and myocardial injury, administering 40 daily hyperbaric oxygen therapy sessions and comparing HO-1 mRNA levels, 6-minute walking distance, and pulmonary arterial pressure before and after treatment.
What They Found
The study found that pulmonary arterial pressure significantly decreased by 8.65 ± 4.91 over 12 weeks (P = 0.0092). Additionally, the 6-minute walking distance increased by 28 ± 10.88 meters at the end of the study (P = 0.0084).
What This Means for Canadian Patients
For Canadian patients experiencing acute carbon monoxide poisoning with myocardial injury, these findings suggest that hyperbaric oxygen therapy could potentially improve their heart function and physical endurance. This may lead to better recovery outcomes and an enhanced quality of life following such a serious event.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is its small sample size of 20 patients and the quasi-experimental design which lacks a control group of CO-poisoned patients not receiving hyperbaric oxygen therapy.